Spine Position and Neural Sensitivity

May 9, 2023 updated by: University of Hartford

The Influence of Spine Position on Measures of Lower Extremity Neural Sensitivity

The purpose of this research study is to see if there is a relationship between the tightness of the hamstring muscles (muscles on the back of the thighs), reported sensations related to stretch of the nerves of the lower extremity, and different positions of participants' backs. We will investigate the qualitative differences as provided verbally by participants (sensation felt at maximum knee extension angle) and quantitative differences as provided by surface electromyographic (EMG) measurements of hamstring activity and inclinometer measures of the knee angle.

Study Overview

Detailed Description

The Slump Test, introduced by Maitland in 1978, has been a clinical staple for determining adverse neural tension or altered neurodynamics and neurosensitivity related to intradiscal derangement or stenotic narrowing of the lumbar spine. The slump test is a highly reliable, common clinical tool used to assess neural tissue mechanosensitivity in patients with both spinal and lower limb pain. However, it is unclear if the slump test can be used to differentiate between those with true adverse neural tension compared to those with neurosensitivity due to compression of the neuroforaminal interface. The positioning of the slump test places maximal tension on the neural tissues both caudally and cranially, either reducing knee extension angle (KEA) in the affected side as opposed to the unaffected side, provoking radicular symptoms, or both. Hall's research found that there was mechanical activity in the hamstring muscles that came on with neural tension testing. This finding can be used to objectively assess when a participant is at their peak tolerable limit of neural tension in specific trunk positions during the slump test. Observation and clinical experience suggest there may be a subset of individuals who have increased neural tension in the slump test during spinal extension (shortening of the nerves) as opposed to flexion (stretch of the nerves). To date, there has been little research that has objectively demonstrated how trunk position affects neural tension during the slump test. Our research aims to determine if there is a difference in patient reported symptoms and hamstring activity between trunk flexion and extension during the slump test with healthy, younger individuals with no recent history of low back pain (LBP) or related symptoms. We expect to find a difference in range of motion (ROM), symptoms, and hamstring activity when the slump test is done in spinal flexion as opposed to spinal extension. This research will help to establish the prevalence of greater sensitivity in the extended vs flexed posture and establish a normative set of symptoms as described by healthy individuals.

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Connecticut
      • West Hartford, Connecticut, United States, 06117
        • University of Hartford

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • healthy individuals between the ages of 18 and 65 without low back pain.

Exclusion Criteria:

  • Known previous diagnoses of sciatica or disc herniation
  • Diagnosis of scoliosis
  • History of pain in the low back or back of the leg
  • History of back surgeries
  • Any recent hamstring injuries
  • Any recent fractures
  • History of osteoporosis
  • Have feeling of pins and needles down the leg
  • Have a known nervous system disorder
  • Have a known systemic inflammatory condition
  • Have Rheumatoid Arthritis
  • Known history of cardiovascular issues
  • Have a known connective tissue disorder
  • Bowel/bladder issues
  • Are or may be pregnant
  • Type 1 or type 2 diabetes mellitus
  • Active/history of cancer
  • Allergy to adhesives
  • Are actively involved in a lawsuit regarding personal bodily injury or receiving workman's compensation
  • Currently taking/have recently taken antibiotics known as fluoroquinolones (ie. Cipro, Levaquin, Noroxin)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: neural tension testing
All participants in this arm will undergo four tests: KEA, SLR, Slump, and Extended Slump

Knee Extension Angle (KEA):

  • This test will be administered with an ankle-foot orthosis (AFO) maintaining the participants ankle in neutral.
  • The participant will lie supine on the examination table with the contralateral lower extremity (LE) stabilized on the support surface using a mobilization strap.
  • The hip of the lower being examined will be flexed to 90 degrees.
  • The participant will then actively straighten their lower leg while maintaining upper leg in same position
  • Once the participant feels they are at maximal knee extension (patient instructed to straighten leg as far as what is comfortable), the angle will be measured with iPhone Inclinometer.
  • Participant asked to report any symptoms they are feeling and where (recorded for qualitative analysis)
Other Names:
  • KEA

Straight Leg Raise (SLR):

  • Position the participant in supine on the plinth with knees extended and L LE strapped to the plinth
  • The participant will keep the AFO donned on the R distal ankle to keep the ankle in neutral position.
  • A researcher will passively lift the participant's right leg moving at a slow but consistent pace of approximately 15 degrees per second, while keeping it straight until a significant resistance is detected or the participant reports a production of symptoms, whichever occurs first.
  • Measurement of the SLR angle will be assessed with iPhone inclinometer.
  • Participant asked to report any symptoms they are feeling and where (recorded for qualitative analysis)
Other Names:
  • SLR

Slump Test Procedure:

  • Participant will be instructed to sit upright with their legs over the edge of table
  • AFO remains on R leg
  • Participant will sequentially flex trunk, look down at the floor
  • Participant will extend R knee until symptoms are felt. Measure of angle with iPhone inclinometer placed at superior aspect of medial malleolus
  • Participant asked to report any symptoms they are feeling and where (recorded for qualitative analysis)

Extended Slump Procedure:

  • Participant will be instructed to sit upright with their legs over the edge of table
  • AFO remains on R leg
  • Participant is asked to arch their lower back into maximal extension in sitting, stabilized to research bench to maintain hyper-lordosis posture.
  • The participant is asked first flex cervical spine, then to extend their knee until it reaches full ROM or symptoms are felt that limit ROM.
  • Knee extension ROM is assessed with iPhone inclinometer at superior aspect of medial malleolus.
  • Participant asked to report any symptoms they are feeling and where (recorded for qualitative analysis)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Knee Extension Angle
Time Frame: single testing session at enrollment
A measurement of the degree of knee extension achieved during the KEA, Slump, and extended slump tests
single testing session at enrollment

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
EMG activity, biceps femoris
Time Frame: single session at enrollment
surface EMG activity of the biceps femoris during KEA, SLR, slump, and extended slump referenced to hamstring maximal voluntary isometric contraction
single session at enrollment
qualitative data- extent, nature, and intensity of pain
Time Frame: single testing session at enrollment
for each test, the most distal extent of symptoms and intensity on the 11 point numeric pain rating scale will be collected. Participants will be asked to describe the nature of the symptoms experienced during the test (e.g. stretch, pain, pull, tingle, etc)
single testing session at enrollment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Brian Swanson, PT, DSc, University of Hartford

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 28, 2022

Primary Completion (Actual)

July 31, 2022

Study Completion (Actual)

July 31, 2022

Study Registration Dates

First Submitted

March 28, 2022

First Submitted That Met QC Criteria

March 28, 2022

First Posted (Actual)

April 6, 2022

Study Record Updates

Last Update Posted (Actual)

May 10, 2023

Last Update Submitted That Met QC Criteria

May 9, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Data will be shared upon request following completion of this study

IPD Sharing Time Frame

Following study completion and manuscript submission

IPD Sharing Access Criteria

upon request

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe